Inhibitors | Comment | Organism | Structure |
---|---|---|---|
FY-CHO | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
extracellular | the enzyme is secreted | Homo sapiens | - |
- |
lysosome | - |
Homo sapiens | 5764 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P07711 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
epithelial ovarian cancer cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Z-Val-Val-Arg-AMC + H2O | a cathepsin L-specific substrate | Homo sapiens | Z-Val-Val-Arg + 7-amino-4-methylcoumarin | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cathepsin L1 | - |
Homo sapiens |
CathL | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
metabolism | CathL acts as an extracellular ligand and plays an important pro-angiogenic, and thus pro-metastatic, role during epithelial ovarian cancer metastasis to the omentum, by activating the omental microvasculature | Homo sapiens |
physiological function | cathepsin L (CathL) is a cysteine endopeptidase, that physiologically plays an important role in degrading endocytosed proteins as well as intracellular proteins. Cathepsin L induces proangiogenic changes in human omental microvascular endothelial cells via activation of the ERK1/2 pathway. Epithelial ovarian cancer (EOC) cells secrete a range of factors with potential pro-angiogenic activity, in disease-relevant human omental microvascular endothelial cells (HOMECs), including the lysosomal protease cathepsin L (CathL), potential pro-proliferative and pro-migratory effects of CathL in HOMECs and the activated signalling pathways. CathL activates the proliferative kinases ERK1/2 and AKT | Homo sapiens |